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A bs tr ac t
Background
In renal Fanconi’s syndrome, dysfunction in proximal tubular cells leads to renal losses 
of water, electrolytes, and low-molecular-weight nutrients. For most types of isolated 
Fanconi’s syndrome, the genetic cause and underlying defect remain unknown.
Methods
We clinically and genetically characterized members of a five-generation black family 
with isolated autosomal dominant Fanconi’s syndrome. We performed genomewide 
linkage analysis, gene sequencing, biochemical and cell-biologic investigations of 
renal proximal tubular cells, studies in knockout mice, and functional evaluations 
of mitochondria. Urine was studied with the use of proton nuclear magnetic reso-
nance (1H-NMR) spectroscopy.
Results
We linked the phenotype of this family’s Fanconi’s syndrome to a single locus on 
chromosome 3q27, where a heterozygous missense mutation in EHHADH segregated 
with the disease. The p.E3K mutation created a new mitochondrial targeting motif 
in the N-terminal portion of EHHADH, an enzyme that is involved in peroxi-
somal oxidation of fatty acids and is expressed in the proximal tubule. Immuno-
cytofluorescence studies showed mistargeting of the mutant EHHADH to mito-
chondria. Studies of proximal tubular cells revealed impaired mitochondrial 
oxidative phosphorylation and defects in the transport of fluids and a glucose ana-
logue across the epithelium. 1H-NMR spectroscopy showed elevated levels of mito-
chondrial metabolites in urine from affected family members. Ehhadh knockout 
mice showed no abnormalities in renal tubular cells, a finding that indicates a 
dominant negative nature of the mutation rather than haploinsufficiency.
Conclusions
Mistargeting of peroxisomal EHHADH disrupts mitochondrial metabolism and 
leads to renal Fanconi’s syndrome; this indicates a central role of mitochondria in 
proximal tubular function. The dominant negative effect of the mistargeted protein 
adds to the spectrum of monogenic mechanisms of Fanconi’s syndrome. (Funded 
by the European Commission Seventh Framework Programme and others.)
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The kidney plays a crucial role in maintaining fluid and electrolyte homeo-stasis. In adults, selective filtration by the 
renal glomerulus produces more than 150 liters 
of ultrafiltrate every day, 99% of which must be 
reabsorbed by highly specialized segments of the 
renal tubule. Impaired function of the first post-
glomerular segment, the proximal tubule, can cause 
massive and life-threatening losses of fluids, elec-
trolytes, and low-molecular-weight nutrients. Such 
dysfunction, known as renal Fanconi’s syndrome 
since the early 1900s (for a historical overview, 
see Kleta and Gahl1), most often occurs in chil-
dren as part of multisystem metabolic diseases 
such as cystinosis, Dent’s disease, the Fanconi–
Bickel syndrome, the oculocerebrorenal syndrome 
(Lowe’s syndrome), tyrosinemia type I, Wilson’s dis-
ease, fructose intolerance, galactosemia, the ARC 
(arthrogryposis, renal dysfunction, and cholestasis) 
syndrome, and mitochondrial disorders. In both 
children and adults, acquired Fanconi’s syndrome 
may result from toxic effects of anti–human im-
munodeficiency virus drugs, heavy metals, anti-
biotics, valproic acid, glue sniffing, or exposure 
to suramin, fumaric acid, or ifosfamide.2,3 Fi-
nally, there have been rare cases of severe, iso-
lated renal Fanconi’s syndrome in which the mo-
lecular, biochemical, and cellular defects remain 
unknown.4 Elucidation of these defects might 
provide a better understanding of the mecha-
nisms of tubular reabsorption and lead to new 
therapeutic interventions.
One possible cause of renal Fanconi’s syndrome 
involves impaired mitochondrial function, because 
the high metabolic activity of the proximal tubule 
makes it particularly susceptible to restrictions 
in energy output.5 Mitochondrial production of 
ATP, which is essential for generating the energy-
dependent ion gradients that drive renal tubular 
reabsorption, is impaired in acute kidney injury.6 
Nevertheless, the mechanism whereby a genetic 
defect in a mitochondrial protein can damage 
tubular function has not been delineated. We 
studied a family with isolated, idiopathic renal 
Fanconi’s syndrome in an effort to identify the 
molecular, biochemical, and cellular defects that 
result in impaired renal tubular reabsorption.
Me thods
Patients
Seven members of a black family with general-
ized Fanconi’s syndrome were admitted to the 
National Institutes of Health Clinical Center and 
enrolled in a clinical protocol for the diagnosis 
and treatment of inborn errors of metabolism and 
other genetic defects. Eleven other family mem-
bers (two of whom had Fanconi’s syndrome) were 
evaluated locally. All gave written informed con-
sent. The diagnosis of Fanconi’s syndrome was 
established by means of routine laboratory tests 
of urine and blood samples. All investigations, 
including genetic studies, were approved by the 
institutional review board of the National Human 
Genome Research Institute and were conducted 
according to the principles of the Declaration 
of Helsinki. Proton nuclear magnetic resonance 
(1H-NMR) spectroscopy7 was used to assess urine 
samples from patients, as compared with samples 
from unaffected family members (see the Meth-
ods section in the Supplementary Appendix, avail-
able with the full text of this article at NEJM.org). 
Genetic Studies
DNA was isolated from whole blood with the use 
of standard procedures and was genotyped with 
2000 highly polymorphic sequence-tagged site 
markers by the company deCODE Genetics. Multi-
point parametric linkage analysis was performed 
with the use of established procedures.8 Coding 
exons and splice sites for all genes within the 
linked locus were sequenced with the use of tra-
ditional Sanger sequencing technology (Trans-
genomic). Recognized sequence variants were 
examined for segregation in all nine affected 
persons and in nine unaffected persons. Sequence 
variants were tested for their presence or absence 
in 200 control alleles each from black persons and 
from white persons (Coriell Institute for Medical 
Research). Public databases (dbSNP, build 137, and 
the 1000 Genomes Project, release 12) were also 
searched. Observed new sequence variants were 
assessed for uniqueness, conservation in various 
species, and potential effects on intracellular tar-
geting (see the Methods section in the Supple-
mentary Appendix).
Renal Proximal Tubular Cell Line
A permanently transfected, inducible renal proxi-
mal tubular cell line derived from LLC-PK1 cells 
and carrying the identified mutation in EHHADH 
was created with the use of recombinant technol-
ogy.9 LLC-PK1 cells are an established model and 
reliably express many properties of the renal 
proximal tubule.3,10 Renal and intracellular lo-
calization of EHHADH was studied; EHHADH is 
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involved in peroxisomal oxidation of fatty acids 
and is expressed in the proximal tubule. Fluid 
transport in the proximal tubule (i.e., formation 
of fluid-filled domes and transport of specific 
substrates) was assessed with the use of estab-
lished techniques.11 For electron-microscopic stud-
ies and assessment of mitochondrial respiratory 
function, cells were prepared and investigated 
with the use of established procedures12,13 (see the 
Methods section in the Supplementary Appendix).
Coimmunoprecipitation of EHHADH
Nonmutant EHHADH and mutant EHHADH were 
coimmunoprecipitated with HADHA and HADHB 
(hydroxyacyl–coenzyme A [CoA] dehydrogenase–
3-ketoacyl-CoA thiolase–enoyl-CoA hydratase), 
which are parts of the heterodimeric enzyme com-
plex (mitochondrial trifunctional protein), with the 
use of an anti-HADHB antibody. Immunoblotting 
was performed with the use of an anti-EHHADH 
antibody (detailed in the Methods section in the 
Supplementary Appendix).
Ehhadh Knockout Mice
We previously generated Ehhadh knockout mice 
to study the biochemical function of the peroxi-
somal protein EHHADH.14 The mice were viable 
and did not have detectable gross phenotypic de-
fects (Fig. S1 in the Supplementary Appendix). 
Levels of urinary phosphate and urinary metabo-
lites were assessed in knockout and control mice 
with the use of established analytic procedures.15 
Bone studies were performed in the mice at 45 
and 51 weeks of age. For details of the studies 
in knockout mice, see the Methods section in 
the Supplementary Appendix.
R esult s
Family Studies
Renal Fanconi’s syndrome was inherited in an 
autosomal dominant fashion in this extended 
black family (Fig. 1A) and was manifested as 
rickets (Fig. 1B), impaired growth, glucosuria 
(Fig. 1C), generalized aminoaciduria, phosphatu-
ria, metabolic acidosis, and low-molecular-weight 
proteinuria (Table S1 in the Supplementary Ap-
pendix). Glomerular function, determined on the 
basis of creatinine measurements in plasma and 
24-hour urine specimens, was normal.16 The af-
fected 74-year-old matriarch presented with slightly 
impaired kidney function (plasma creatinine level, 
1.4 mg per deciliter [124 μmol per liter]) but had 
had normal kidney function at 58 years of age (plas-
ma creatinine level, 1.1 mg per deciliter [97 μmol 
per liter]). Urinary protein excretion in affected 
family members was as high as 1.2 g per day but 
was not associated with renal failure.16 Affected 
persons in this family, ranging in age from 1 to 
74 years, had uneventful gestational, birth, and 
infancy histories. The primary clinical manifes-
tation was rickets, due mainly to renal phosphate 
losses, with bowing of legs from early childhood. 
All known causes of Fanconi’s syndrome had 
been previously ruled out.
Metabolomic analysis, including univariate 
significance testing and principal-component 
analysis, was performed on urine samples from 
the affected family members and from unaffected 
family members. Metabolic analysis revealed a 
unique clustering that differentiated the two 
groups (Fig. S2 in the Supplementary Appendix). 
In addition, 1H-NMR spectroscopy identified met-
abolic markers that were indicative of mito-
chondrial dysfunction (Fig. 1D, and Table S2 in 
the Supplementary Appendix).
Genetic Analyses
We performed genomewide linkage analysis and 
found significant linkage in a single region (LOD 
score >3); the disease segregated in an autosomal 
dominant fashion with a haplotype on chromo-
some 3q27 (Fig. 2A). That haplotype, shared by all 
affected family members and not found in any 
unaffected members, was flanked by markers 
D3S3583 and D3S2747 (Fig. 2B). By sequencing 
all known genes (coding and noncoding exons 
and splice sites) in this linked region, we identi-
fied a single heterozygous missense mutation 
(c.7G→A, p.E3K) in EHHADH (Fig. 2C). The muta-
tion segregated completely in all affected per-
sons and was absent from unaffected relatives, 
black controls, and all available databases. This 
heterozygous change of a highly conserved gluta-
mate to lysine in the third amino acid position of 
EHHADH (Fig. 2C and 2D) predicted the de novo 
creation of an N-terminal mitochondrial target-
ing motif in this peroxisomal protein (Fig. S3 in 
the Supplementary Appendix).17
Cell Studies
We used LLC-PK1 cells that were permanently 
transfected with normal or mutant EHHADH as 
a cellular model to study the function and mor-
phology of the proximal tubule. The control 
(nonmutant) EHHADH localized only to peroxi-
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somes. However, as predicted by our bioinfor-
matic analyses, mutant EHHADH localized to 
mitochondria as well as to peroxisomes, a find-
ing that was confirmed by colocalization with 
an established mitochondrial marker. Local-
ization to mitochondria, in addition to peroxi-
somes, was also seen in COS-7 and human em-
bryonic kidney 293 (HEK293) cells. Electron 
microscopy revealed no morphologic abnormal-
ities in the mitochondria of LLC-PK1 cells that 
were transfected with the mutant EHHADH 
(Fig. S3 in the Supplementary Appendix).
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Figure 1. Clinical Characteristics of the Family Members.
The family pedigree (Panel A) shows autosomal dominant inheritance of Fanconi’s syndrome. Squares denote male family members,  circles 
female family members, solid symbols family members with Fanconi’s syndrome, and symbols with slashes deceased family members. DNA 
indicates that the person contributed to the linkage studies. A radiograph (Panel B) of the hips, femurs, and knees of an affected 12-year-old 
girl shows substantial femoral deformity, loss of bone density, and evidence of rickets. Urine dipstick analyses (Panel C) in unaffected 
family members (columns A through I) and affected family members (columns J through P) reveal glucosuria (row 5) only in family 
members with Fanconi’s syndrome. There were false negative findings (almost no change of color) for low-molecular-weight proteinuria 
(row 4) in affected persons. A bar plot (Panel D) shows the abundances of metabolites in urine that differed significantly between affected 
family members and unaffected family members. Abundances were established by means of proton nuclear magnetic resonance spec-
troscopy. The height of the bars is the geometric mean relative concentration adjusted for the urine creatinine concentration, and the 
T bars indicate standard errors. There were significant elevations of lactate, acetate, succinate, fumarate, citrate, and creatine in addition 
to glucose and selected amino acids.
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In contrast, permanently transfected renal prox-
imal tubular cells carrying the family’s EHHADH 
mutation exhibited a reproducible and specific 
defect in the transepithelial transport of fluids, 
which is a key tubular function. This defect was 
reflected in the inability to maintain fluid-filled 
domes in confluent monolayers (Fig. S3 in the Sup-
plementary Appendix); such dome formation is 
a recognized characteristic of healthy cells.10,18 
In addition, luminal-to-basolateral transport of 
methyl α-d-glucoside, a surrogate for transepi-
thelial glucose reabsorption, was significantly 
reduced (Fig. 3A). Furthermore, high-resolution 
respiratory measurements confirmed an impair-
ment of mitochondrial energy generation. Specifi-
cally, the proximal tubular cells that were trans-
fected with the mutant EHHADH, as compared 
with control EHHADH, showed significantly 
less capacity for oxidative phosphorylation, a 
finding that is compatible with an impairment 
of ATP production (Fig. 3B, and Fig. S4 in the 
Supplementary Appendix). Mutant EHHADH co-
immuno precipitated with mitochondrial HADHA 
and HADHB (Fig. 3C), indicating an interaction 
of the mistargeted EHHADH with mitochondria 
that is expected to interfere with mitochondrial 
function.
Renal in Situ Immunostaining
In human kidney specimens, strong EHHADH 
staining was detected in the terminal segments of 
the proximal tubule, suggesting a role of EHHADH 
in human kidney physiological processes. In stud-
ies of kidney slices obtained from normal mice, 
immunofluorescence staining showed endogenous 
EHHADH only in the terminal proximal tubule 
(Fig. S5 in the Supplementary Appendix).
Mouse Models
We used Ehhadh−/− mice to determine whether per-
oxisomal EHHADH haploinsufficiency was likely 
to have caused Fanconi’s syndrome in the family 
we studied. We did not observe aminoaciduria or 
glucosuria in these mice (Fig. S6 in the Supple-
mentary Appendix), nor did we observe phospha-
turia (phosphate excretion [in micromoles] correct-
ed for urine creatinine concentration [in millimoles], 
8.2±2.7 in five Ehhadh−/− mice and 6.0±1.2 in nine 
control mice; P = 0.48). We further tested for mark-
ers of mitochondrial dysfunction in this knockout 
model. Mitochondrial dysfunction is often ac-
companied by elevated excretion of energy inter-
mediates, such as lactate and 3-hydroxybutyrate, 
and impairment of the tricarboxylic acid cycle, 
with accumulation of succinic acid, fumaric acid, 
malic acid, and citric acid. In addition, when oxi-
dative phosphorylation is disturbed, cells exhibit 
increased glycolysis, resulting in elevated levels 
of glycolytic intermediates (e.g., glyceric acid) as 
well as an altered lactate:pyruvate ratio. In the 
Ehhadh knockout mice, however, urinary excre-
tion of these organic compounds was normal 
(Fig. S6 in the Supplementary Appendix), and the 
lactate:pyruvate ratio (with both lactate and pyru-
vate measured in micromoles per millimole of 
creatinine) was similar to that in control mice 
(1.33±0.35 in Ehhadh−/− mice and 1.55±0.26 in con-
trol mice; P = 0.62). Taken together, these data in-
dicate that a lack of EHHADH had no significant 
effect on mitochondrial function and suggest 
that mistargeting of mutant EHHADH to mito-
chondria, in a dominant negative fashion, is the 
disease-causing mechanism.
Discussion
Renal Fanconi’s syndrome comprises a heteroge-
neous group of disorders characterized by proxi-
mal tubular dysfunction leading to generalized 
aminoaciduria, glucosuria, phosphaturia, low-
molecular-weight proteinuria, and metabolic aci-
dosis due to renal bicarbonate losses.19 When renal 
Fanconi’s syndrome occurs as a result of multi-
system disease, early diagnosis may facilitate 
therapy directed at the basic defect.20 When Fan-
coni’s syndrome is isolated, however, treatment 
is largely symptomatic because the basic defect is 
generally unknown. Exceptions include genetic 
disorders causing a partial Fanconi’s syndrome4,21 
(e.g., renal glucosuria due to biallelic SGLT2 mu-
tations22 and phosphaturia associated with auto-
somal recessive deficiency of phosphate trans-
port23). Our study elucidates the molecular basis 
of renal Fanconi’s syndrome in a family.
Over time, several hypotheses concerning the 
defect in proximal tubular function in Fanconi’s 
syndrome have been proposed, including changes 
in membrane fluidity, increased paracellular 
permeability with increased back flux, decreased 
luminal uptake, and decreased basolateral trans-
port from within the cell to the blood or in-
creased back flux from the blood toward the 
cells.24 In Fanconi’s syndrome that is due to 
systemic disease, renal tubular cells may be de-
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stroyed directly. In isolated Fanconi’s syndrome 
resulting from a genetic defect, energy produc-
tion in proximal tubular cells may be impaired, 
impeding the capacity for reabsorption of low-
molecular-weight proteins.
Remarkably, proximal tubular cells do not 
use glucose for their energy production25; fatty 
acid oxidation is the predominant energy source. 
Moreover, mitochondria rather than peroxi-
somes perform most of this function in proxi-
mal tubular cells. Indeed, patients with typical 
mitochondrial disorders often have Fanconi’s 
syndrome as part of their disease.26 Despite 
widespread acceptance of the requirement of 
mitochondrial function for renal tubular reab-
sorption, however, isolated cases of Fanconi’s 
syndrome resulting from mitochondrial dys-
function have not been noted.
Our studies involving a family with renal 
Fanconi’s syndrome and severe rickets provided an 
opportunity to examine this functional relation-
ship. Affected family members had generalized 
renal Fanconi’s syndrome involving defective 
reabsorption of phosphate, glucose, bicarbonate, 
amino acids, water, and low-molecular-weight 
proteins. They also had a pathogenic mutation 
(p.E3K) in EHHADH.
This gene encodes the bifunctional peroxisomal 
enzyme enoyl-CoA hydratase–L-3-hydroxyacyl-CoA 
dehydrogenase, also referred to as L-bifunctional 
enzyme or L-PBE, which functions primarily in 
peroxisomal beta-oxidation of straight-chain sat-
urated acyl-CoA fatty acids27,28 and can be in-
duced by ligands of the nuclear receptor peroxi-
some proliferator–activated receptor α (PPAR-α). 
The first and rate-limiting step of the beta-oxi-
dation pathway is catalyzed by the fatty acid 
acyl-CoA oxidase, and the second and third reac-
tions are carried out by EHHADH. The fourth and 
final step is catalyzed by 3-ketoacyl-CoA thiolase. 
A bifunctional enzyme called D-bifunctional 
enzyme, which is functionally homologous to 
EHHADH, also provides for the second and the 
third steps of the beta-oxidation pathway as a 
noninducible system acting on branched-chain 
acyl-CoA fatty acids.
Despite these known roles of L-PBE in peroxi-
somal oxidation pathways, it plays a minor role 
in overall fatty acid oxidation and energy produc-
tion, as indicated by the fact that Ehhadh knock-
out mice are viable and ostensibly unaffected.29 
In the Ehhadh−/− mice that we studied, classic 
peroxisomal beta-oxidation was disrupted owing 
to removal of exon 4 in the L-PBE gene.14 Never-
theless, these mice were fertile and had no gross 
phenotypic defects, suggesting that their mito-
chondria provided sufficient energy for growth 
and development. Specifically, proximal tubular 
function was not impaired in the Ehhadh knock-
out mice, as shown by the absence of glucosuria, 
phosphaturia, and aminoaciduria. Moreover, mito-
chondrial function appeared to be preserved, with 
normal urinary excretion of organic acids and 
normal levels of glycolytic intermediates.
These findings argue against a haploinsuffi-
ciency model of disease in our patients and ar-
gue for a dominant negative effect of the mutant 
allele on proximal tubular reabsorption. In par-
ticular, the p.E3K mutation in EHHADH targeted 
the mutant protein mainly to mitochondria in-
stead of peroxisomes (Fig. S3 in the Supplemen-
tary Appendix), as a result of the creation of a 
new targeting signal in the N-terminal of the 
protein. This finding is consistent with the gen-
eral consensus that targeting motifs for mito-
chondrial proteins often occur at the N-terminal 
of the protein and that targeting motifs for per-
oxisomal proteins occur at the C-terminal of the 
protein. Mistargeting of a peroxisomal protein to 
mitochondria occurs in another metabolic disease, 
autosomal recessive primary hyperoxaluria.30 In 
that case, however, the cause of the disease is an 
absence of peroxisomal enzymatic activity.
Because mitochondria are critical for energy 
production in renal proximal tubules, we investi-
Figure 2 (facing page). Results of Linkage Studies and 
Sequence Analysis.
Panel A shows the results of multipoint parametric 
linkage analysis for chromosome 3. There was distinct 
and significant linkage (LOD score, 3.61) in the region 
of 200 cM. Panel B shows a haplotype reconstruction 
for the family at this locus, with segregation of the dis-
ease allele (shown in orange; D3S3583–D3S2747) in all 
affected family members. Other colors represent other 
haplotypes. Panel C shows original sequence chromato-
grams for a portion of exon 1 of EHHADH for an affected 
family member (patient) and her unaffected offspring 
(control). There is a heterozygous missense mutation, 
c.7G→A (GAG→AAG; p.E3K), in the patient’s chromato-
gram (arrow). Panel D shows a protein-alignment (ho-
mology) plot of the first 25 amino acids of EHHADH 
in 11 vertebrate genera, with complete conservation  
of the E3 locus (arrow).
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gated the effect of misdirected mutant EHHADH 
on mitochondrial function. Respirometric mea-
surements of cells expressing mutant EHHADH 
showed a reduced capacity of the oxidative phos-
phorylation pathway, and 1H-NMR spectroscopy 
of urine specimens from affected family mem-
bers showed specific elevations of mitochondrial 
metabolites.
Our data suggest that the isolated complexes 
of the respiratory chain are working normally 
but that the activity of the phosphorylation sys-
tem (e.g., function of ATP synthase) becomes 
rate-limiting. One possible mechanism for the 
dominant negative effect of a mutant EHHADH 
protein on mitochondrial function involves im-
paired beta-oxidation of fatty acids. There is a 
high degree of homology between the peroxi-
somal bifunctional protein (EHHADH) and the 
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mitochondrial trifunctional protein, which plays 
the dominant role in overall energy production. 
Because the mitochondrial trifunctional protein 
is a heterodimeric octamer, the mutant EHHADH 
(which, after import and loss of its leader se-
quence, shows high homology to the mitochon-
drial trifunctional protein) appears to interact 
with normal mitochondrial subunits of the mito-
chondrial trifunctional protein and to functionally 
disrupt some of these multimers (Fig. 3C and 3D). 
The extent of dysfunction is dependent on the 
ratio of abnormal to normal subunits and the 
affinity of the mutant EHHADH protein for 
octameric partners. In any event, there appears 
to be sufficient disruption of mitochondrial 
energy metabolism to impair reabsorption in 
the renal proximal tubules, as indicated by our 
clinical findings and our in vivo and in vitro 
studies. However, the possibility of an addi-
tional dominant negative effect of the mutant 
EHHADH on peroxisomal function cannot be 
excluded.
The findings in this family indicate that a 
monogenic defect leading to intracellular mis-
targeting of a mutant protein can result in mito-
chondrial damage and isolated organ disease 
— in this case, renal Fanconi’s syndrome.31 The 
explanation lies in the unique and particular 
energy requirements of proximal tubular cells 
for fatty acid oxidation, combined with the sin-
gular disruption of mitochondrial beta-oxida-
tion by the mistargeting of a mutated peroxi-
somal protein. The elucidation of this defect 
allows for molecular screening of other family 
members and the possibility of early interven-
tion to prevent rickets.
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Figure 3 (facing page). Results of Functional Studies in Cell Culture.
Panel A shows the results of transport studies in inducible, permanently transfected LLC-PK1 cells expressing non-
mutant or mutant EHHADH. Cells were grown on permeable supports, and the nonmetabolizable glucose surrogate 
methyl α-d-glucoside was used as substrate for Na+-coupled glucose transport. Cells overexpressing the mutant 
EHHADH exhibited a significantly reduced transport capacity as compared with cells overexpressing the nonmutant 
protein. I bars indicate standard errors (SE). Panel B shows the results of a high-resolution respi rometry experiment 
in inducible, permanently transfected LLC-PK1 cells expressing nonmutant or mutant EHHADH. Oxygen consumption 
of mitochondria was determined as an indirect measure of oxidative phosphorylation. No significant differences in 
endogenous respiration were observed in intact cells. After permeabilization of the cell membrane with digitonin 
and the addition of saturating substrates for complex I, complex II, and adenosine diphosphate, cells expressing 
 mutant EHHADH had a significantly reduced capacity for oxidative phosphorylation (P<0.001). After inhibition of 
the ATP synthase (with oligomycin) and uncoupling (with p-trifluoromethoxy carbonyl cyanide phenyl hydrazone 
[FCCP]), the difference in oxygen consumption was abolished, pointing toward a dysfunction in ATP production.  
For details, see the Methods section and Figure S4 in the Supplementary Appendix. Values are means ±SE, nor malized 
to citrate synthase (CS) activity. Panel C shows the results of coimmunoprecipitation of EHHADH with HADHA and 
HADHB (hydroxyacyl–coenzyme A [CoA] dehydrogenase–3-ketoacyl-CoA thiolase–enoyl-CoA hydratase) with the use 
of an anti-HADHB antibody. Immunoblotting against EHHADH showed a distinct band for the  mutant EHHADH, indi-
cating that the mutant protein is incorporated into the mitochondrial trifunctional enzyme, whereas the absence of a 
band for the nonmutant protein indicates negligible incorporation. Immuno blotting against the “bait” protein HADHB 
and its known interactor, HADHA, showed similar intensities in LLC-PK1 cells  expressing nonmutant EHHADH and 
those expressing mutant EHHADH. Panel D shows a proposed model of a dominant negative effect of mutant peroxi-
somal L-bifunctional enzyme (L-PBE) (EHHADH) disrupting the mitochondrial trifunctional protein hetero-octamer 
(composed of HADHA and HADHB) in the renal proximal tubule. Glucose is reabsorbed from the luminal (urine-side) 
membranes to the basolateral (blood-side) membranes and is not used for energy production. Most of the basolateral 
fatty acid uptake is used for mitochondrial energy production by means of trifunctional protein (HADHA and HADHB). 
A small fraction of the fatty acid uptake is used for peroxisomal energy production by means of bifunctional protein 
(D-bifunctional enzyme [D-PBE]). The physiological targeting motif, SKL, normally directs L-PBE to the peroxisome. 
The E3K mutation instead creates a targeting motif that directs L-PBE to the mitochondrion, where its homology causes 
it to interfere with the assembly and function of trifunctional protein.
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